| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | SATB2 POLA1 CHAF1A CHD5 SMARCC2 L3MBTL3 MNT TRIM37 CIC PHF13 BAHCC1 | 1.35e-04 | 739 | 78 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.77e-04 | 147 | 78 | 5 | GO:0042826 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 5.11e-04 | 40 | 78 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | adenylate kinase activity | 5.33e-04 | 9 | 78 | 2 | GO:0004017 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 7.23e-04 | 45 | 78 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | kinase activity | 7.60e-04 | 764 | 78 | 10 | GO:0016301 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 8.10e-04 | 11 | 78 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 9.69e-04 | 12 | 78 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK3 STK4 SMG1 PDGFRA POLA1 CDK11A PIP4K2B PRKD1 AK9 CDK11B AK7 | 1.01e-03 | 938 | 78 | 11 | GO:0016772 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | NPHS1 SMG1 FCHSD2 KANK1 NCAPG HDAC6 MAP1B PDGFRA SMARCC2 CDK11A MCM2 PIP4K2B PRKD1 SMG5 CDK11B HUWE1 ANAPC5 TRIM37 VAT1 | 4.19e-07 | 1342 | 78 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | chromatin organization | SATB2 KMT2D HDAC6 CHAF1A CHD5 BCORL1 SMARCC2 MCM2 LMNB2 HUWE1 L3MBTL3 TRIM37 PHF13 BAHCC1 | 5.91e-06 | 896 | 78 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SATB2 KMT2D HDAC6 CHAF1A CHD5 BCORL1 SMARCC2 MCM2 LMNB2 HUWE1 L3MBTL3 TRIM37 PHF13 BAHCC1 | 2.01e-05 | 999 | 78 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | nuclear export | 7.22e-05 | 185 | 78 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | nuclear transport | 9.06e-05 | 378 | 78 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 9.06e-05 | 378 | 78 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | SATB2 KMT2D HDAC6 CHAF1A CHD5 SMARCC2 MCM2 LMNB2 HUWE1 L3MBTL3 TRIM37 | 1.04e-04 | 741 | 78 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.39e-04 | 515 | 78 | 9 | GO:0022613 | |
| GeneOntologyBiologicalProcess | mitotic DNA replication initiation | 1.40e-04 | 5 | 78 | 2 | GO:1902975 | |
| GeneOntologyBiologicalProcess | nuclear cell cycle DNA replication initiation | 1.40e-04 | 5 | 78 | 2 | GO:1902315 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication initiation | 1.40e-04 | 5 | 78 | 2 | GO:1902292 | |
| GeneOntologyBiologicalProcess | regulation of cell differentiation involved in embryonic placenta development | 1.40e-04 | 5 | 78 | 2 | GO:0060800 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SMG1 LEO1 UPF2 SAFB2 CDK11A RPRD2 SMG5 CDK11B CPSF3 SNRNP200 XAB2 NCBP3 | 1.61e-04 | 917 | 78 | 12 | GO:0016071 |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 1.78e-04 | 74 | 78 | 4 | GO:0006406 | |
| GeneOntologyBiologicalProcess | spliceosomal conformational changes to generate catalytic conformation | 2.10e-04 | 6 | 78 | 2 | GO:0000393 | |
| GeneOntologyBiologicalProcess | mRNA processing | 2.30e-04 | 551 | 78 | 9 | GO:0006397 | |
| GeneOntologyBiologicalProcess | embryo development | STK3 STK4 SATB2 KMT2D LEO1 UTP25 PDGFRA CC2D2A CDK11A AATF ANKRD24 PLCD1 CDK11B NOP2 XAB2 | 2.77e-04 | 1437 | 78 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 2.81e-04 | 336 | 78 | 7 | GO:0042254 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion, centromeric | 2.93e-04 | 7 | 78 | 2 | GO:0071962 | |
| GeneOntologyBiologicalProcess | organelle assembly | DNAAF8 CEP350 ERICH3 MDN1 HDAC6 PDGFRA CC2D2A PIP4K2B PRKD1 RFX3 NOP2 TRIM37 AK7 | 3.18e-04 | 1138 | 78 | 13 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | DNAAF8 CEP350 HDAC6 MAP1B CC2D2A CDK11A CDK11B PARD3 TRIM37 AK7 | 3.73e-04 | 720 | 78 | 10 | GO:0000226 |
| GeneOntologyBiologicalProcess | aggresome assembly | 3.90e-04 | 8 | 78 | 2 | GO:0070842 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 4.09e-04 | 596 | 78 | 9 | GO:0001701 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 4.83e-04 | 96 | 78 | 4 | GO:0006405 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fusion | 5.00e-04 | 9 | 78 | 2 | GO:0010637 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 5.14e-04 | 266 | 78 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | STK3 STK4 SATB2 KMT2D PDGFRA CC2D2A CDK11A PLCD1 CDK11B NOP2 XAB2 | 5.82e-04 | 906 | 78 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 6.12e-04 | 275 | 78 | 6 | GO:0016072 | |
| GeneOntologyBiologicalProcess | positive regulation of protein deacetylation | 6.23e-04 | 10 | 78 | 2 | GO:0090312 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 7.02e-04 | 46 | 78 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.02e-04 | 46 | 78 | 3 | GO:0000184 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | STK3 STK4 SATB2 KMT2D PDGFRA CC2D2A CDK11A PLCD1 CDK11B NOP2 XAB2 | 7.16e-04 | 929 | 78 | 11 | GO:0009792 |
| GeneOntologyBiologicalProcess | ribosomal small subunit biogenesis | 7.53e-04 | 108 | 78 | 4 | GO:0042274 | |
| GeneOntologyBiologicalProcess | primitive hemopoiesis | 9.09e-04 | 12 | 78 | 2 | GO:0060215 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SATB2 KMT2D HDAC6 LEO1 UPF2 POLA1 CHD5 SMARCC2 MCM2 SMG5 MPHOSPH10 ANAPC5 CPSF3 SNRNP200 TRIM37 MXD4 XAB2 BRMS1 | 1.92e-06 | 1377 | 77 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | preribosome | 6.38e-05 | 114 | 77 | 5 | GO:0030684 | |
| GeneOntologyCellularComponent | small-subunit processome | 1.79e-04 | 76 | 77 | 4 | GO:0032040 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.75e-04 | 85 | 77 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | transferase complex | KMT2D LEO1 UBE4B POLA1 FBXO42 PRKAR2B CDK11A CDK11B PARD3 ANAPC5 TRIM37 | 7.72e-04 | 963 | 77 | 11 | GO:1990234 |
| Domain | Mst1_SARAH_domain | 1.63e-05 | 2 | 76 | 2 | IPR024205 | |
| Domain | Mst1_SARAH | 1.63e-05 | 2 | 76 | 2 | PF11629 | |
| Domain | TPR-like_helical_dom | 3.73e-04 | 233 | 76 | 6 | IPR011990 | |
| Domain | SARAH | 5.77e-04 | 9 | 76 | 2 | PS50951 | |
| Domain | SARAH_dom | 5.77e-04 | 9 | 76 | 2 | IPR011524 | |
| Domain | Adenylat/UMP-CMP_kin | 7.20e-04 | 10 | 76 | 2 | IPR000850 | |
| Domain | - | 1.46e-03 | 55 | 76 | 3 | 1.10.30.10 | |
| Domain | - | 1.56e-03 | 207 | 76 | 5 | 1.25.40.10 | |
| Domain | - | 2.32e-03 | 449 | 76 | 7 | 3.30.40.10 | |
| Domain | HMG_box_dom | 2.36e-03 | 65 | 76 | 3 | IPR009071 | |
| Domain | Znf_RING/FYVE/PHD | 2.63e-03 | 459 | 76 | 7 | IPR013083 | |
| Domain | - | 2.96e-03 | 20 | 76 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 2.96e-03 | 20 | 76 | 2 | IPR001279 | |
| Domain | TPR-contain_dom | 3.28e-03 | 150 | 76 | 4 | IPR013026 | |
| Domain | S_TKc | 3.42e-03 | 359 | 76 | 6 | SM00220 | |
| Domain | PHD | 3.54e-03 | 75 | 76 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 4.10e-03 | 79 | 76 | 3 | IPR019787 | |
| Domain | PHD | 5.72e-03 | 89 | 76 | 3 | SM00249 | |
| Domain | Znf_PHD | 6.09e-03 | 91 | 76 | 3 | IPR001965 | |
| Domain | Kinase-like_dom | 6.48e-03 | 542 | 76 | 7 | IPR011009 | |
| Domain | ZF_PHD_2 | 6.85e-03 | 95 | 76 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 7.06e-03 | 96 | 76 | 3 | PS01359 | |
| Domain | Chromo/shadow_dom | 7.95e-03 | 33 | 76 | 2 | IPR000953 | |
| Domain | CHROMO | 7.95e-03 | 33 | 76 | 2 | SM00298 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SATB2 KMT2D NCAPG MDN1 HDAC6 MAP1B CHAF1A FBXO42 SMARCC2 CDK11A SMG5 LMNB2 HUWE1 RFX3 L3MBTL3 SNRNP200 MNT CIC MXD4 GTF3C3 BRMS1 | 1.92e-16 | 857 | 78 | 21 | 25609649 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSP90B1 MDN1 UTP25 PDGFRA CHAF1A SAFB2 SMARCC2 MCM2 NOL7 AATF LMNB2 MPHOSPH10 CDK11B HUWE1 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 NOL8 | 4.13e-14 | 989 | 78 | 20 | 36424410 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KMT2D MDN1 LEO1 CHAF1A BCORL1 SAFB2 NOL7 AATF RPRD2 LMNB2 NOP2 L3MBTL3 ANAPC5 CPSF3 SNRNP200 MNT CIC MXD4 XAB2 NOL8 BRMS1 | 5.93e-13 | 1294 | 78 | 21 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2D MDN1 HDAC6 LEO1 UBE4B CHAF1A SAFB2 SMARCC2 CDK11A MCM2 CDK11B HUWE1 PARD3 NOP2 ANAPC5 SNRNP200 CIC | 1.20e-12 | 774 | 78 | 17 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP1B CHAF1A BCORL1 SAFB2 SMARCC2 CDK11A NOL7 AATF RPRD2 MPHOSPH10 CDK11B NOP2 L3MBTL3 SNRNP200 CIC XAB2 NOL8 NCBP3 | 2.99e-12 | 954 | 78 | 18 | 36373674 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STK4 HSP90B1 NCAPG MDN1 HDAC6 MAP1B UPF2 UBE4B POLA1 SAFB2 SMARCC2 MCM2 AATF LMNB2 HUWE1 PARD3 NOP2 CPSF3 SNRNP200 GTF3C3 | 1.26e-11 | 1353 | 78 | 20 | 29467282 |
| Pubmed | MDN1 UTP25 MAP1B POLA1 SMARCC2 AATF LMNB2 MPHOSPH10 HUWE1 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 | 2.00e-10 | 653 | 78 | 14 | 22586326 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 UTP25 SMARCC2 MCM2 AATF RPRD2 MPHOSPH10 CDK11B HUWE1 NOP2 ANAPC5 GTF3C3 | 2.96e-10 | 440 | 78 | 12 | 34244565 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSP90B1 NCAPG MDN1 UPF2 CHAF1A SAFB2 PRKAR2B MCM2 PIP4K2B NOL7 AATF MPHOSPH10 CDK11B HUWE1 NOP2 CPSF3 SNRNP200 XAB2 | 5.70e-10 | 1318 | 78 | 18 | 30463901 |
| Pubmed | DNAAF8 KMT2D NCAPG CHAF1A SMARCC2 MCM2 CDK11B HUWE1 L3MBTL3 GTF3C3 NCBP3 BRMS1 | 6.11e-10 | 469 | 78 | 12 | 27634302 | |
| Pubmed | 4.57e-09 | 246 | 78 | 9 | 15345747 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP350 HSP90B1 MDN1 MAP1B SAFB2 SMARCC2 MCM2 NOL7 AATF LMNB2 HUWE1 NOP2 SNRNP200 XAB2 NCBP3 | 7.57e-09 | 1024 | 78 | 15 | 24711643 |
| Pubmed | MST1/2 regulates fibro/adipogenic progenitor fate decisions in skeletal muscle regeneration. | 1.09e-08 | 3 | 78 | 3 | 38552635 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MDN1 MAP1B UPF2 SAFB2 NOL7 AATF MPHOSPH10 NOP2 L3MBTL3 SNRNP200 GTF3C3 NOL8 NCBP3 | 1.38e-08 | 759 | 78 | 13 | 35915203 |
| Pubmed | SMG1 HSP90B1 MDN1 LEO1 MAP1B CHAF1A CHD5 SAFB2 CC2D2A SMARCC2 PIP4K2B AATF OTUD3 LMNB2 MPHOSPH10 VAT1 BAHCC1 | 1.64e-08 | 1442 | 78 | 17 | 35575683 | |
| Pubmed | CEP350 NCAPG MAP1B CHAF1A BCORL1 CDK11A PIP4K2B HUWE1 NOP2 L3MBTL3 CPSF3 EDRF1 | 2.13e-08 | 645 | 78 | 12 | 25281560 | |
| Pubmed | HSP90B1 MDN1 SAFB2 SMARCC2 MCM2 AATF MPHOSPH10 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 NOL8 | 4.96e-08 | 847 | 78 | 13 | 35850772 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 5.65e-08 | 153 | 78 | 7 | 26365490 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.59e-08 | 341 | 78 | 9 | 32971831 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 8.36e-08 | 162 | 78 | 7 | 31363146 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 NCAPG MDN1 POLA1 CHAF1A SAFB2 CC2D2A MCM2 NOL7 LMNB2 HUWE1 NOP2 CPSF3 SNRNP200 GTF3C3 VAT1 | 9.06e-08 | 1425 | 78 | 16 | 30948266 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 9.24e-08 | 349 | 78 | 9 | 25665578 | |
| Pubmed | 9.98e-08 | 251 | 78 | 8 | 28077445 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SATB2 MDN1 LEO1 CHD5 SMARCC2 AATF CDK11B NOP2 SNRNP200 XAB2 NCBP3 | 1.09e-07 | 605 | 78 | 11 | 28977666 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | POLA1 CHAF1A CHD5 BCORL1 SMARCC2 NOL7 CDK11B NOP2 CIC GTF3C3 NCBP3 | 1.15e-07 | 608 | 78 | 11 | 36089195 |
| Pubmed | HSP90B1 NCAPG MDN1 POLA1 MCM2 LMNB2 HUWE1 NOP2 CPSF3 SNRNP200 GTF3C3 | 1.86e-07 | 638 | 78 | 11 | 33239621 | |
| Pubmed | CEP350 SMG1 SATB2 KMT2D MDN1 BCORL1 SMARCC2 NOL7 AATF MPHOSPH10 CIC | 1.86e-07 | 638 | 78 | 11 | 31182584 | |
| Pubmed | Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay. | 2.16e-07 | 6 | 78 | 3 | 25770585 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.49e-07 | 283 | 78 | 8 | 30585729 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.57e-07 | 394 | 78 | 9 | 27248496 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SMG1 HSP90B1 KMT2D MAP1B LMNB2 MPHOSPH10 RFX3 SNRNP200 NCBP3 | 3.58e-07 | 410 | 78 | 9 | 26949251 |
| Pubmed | 3.77e-07 | 7 | 78 | 3 | 14636577 | ||
| Pubmed | Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. | 3.77e-07 | 7 | 78 | 3 | 17916692 | |
| Pubmed | NCAPG MDN1 LEO1 POLA1 CHAF1A SAFB2 SMARCC2 MCM2 LMNB2 CDK11B CPSF3 GTF3C3 XAB2 | 3.89e-07 | 1014 | 78 | 13 | 32416067 | |
| Pubmed | CEP350 KANK1 MDN1 HDAC6 MAP1B POLA1 CHAF1A BCORL1 RPRD2 CIC NOL8 | 3.98e-07 | 689 | 78 | 11 | 36543142 | |
| Pubmed | SMG1 SATB2 KMT2D CHD5 BCORL1 SMARCC2 CDK11A RPRD2 SMG5 NOP2 L3MBTL3 MNT CIC GTF3C3 BRMS1 | 5.71e-07 | 1429 | 78 | 15 | 35140242 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CEP350 STK3 MAP1B UPF2 POLA1 AATF SMG5 MPHOSPH10 NOP2 XAB2 NOL8 | 6.47e-07 | 724 | 78 | 11 | 36232890 |
| Pubmed | CEP350 STK4 KANK1 CHAF1A PIP4K2B RPRD2 LMNB2 CDK11B HUWE1 CPSF3 VAT1 | 7.30e-07 | 733 | 78 | 11 | 34672954 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.32e-07 | 332 | 78 | 8 | 32786267 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | STK3 STK4 SMG1 LEO1 UTP25 MAP1B PRKAR2B CDK11A PIP4K2B PRKD1 CDK11B ANAPC5 | 8.53e-07 | 910 | 78 | 12 | 36736316 |
| Pubmed | The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. | 9.03e-07 | 9 | 78 | 3 | 16488880 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CEP350 STK3 STK4 PPP1R7 MDN1 POLA1 PRKAR2B AATF MPHOSPH10 CPSF3 NOL8 | 9.62e-07 | 754 | 78 | 11 | 33060197 |
| Pubmed | 9.72e-07 | 339 | 78 | 8 | 30415952 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.08e-06 | 344 | 78 | 8 | 30333137 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.35e-06 | 154 | 78 | 6 | 16055720 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.70e-06 | 495 | 78 | 9 | 27705803 | |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 1.75e-06 | 161 | 78 | 6 | 32572027 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.87e-06 | 370 | 78 | 8 | 22922362 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.88e-06 | 163 | 78 | 6 | 22113938 | |
| Pubmed | 2.04e-06 | 506 | 78 | 9 | 30890647 | ||
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 2.60e-06 | 270 | 78 | 7 | 24366813 | |
| Pubmed | Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis. | 3.05e-06 | 13 | 78 | 3 | 29712669 | |
| Pubmed | 3.36e-06 | 538 | 78 | 9 | 28524877 | ||
| Pubmed | 3.50e-06 | 403 | 78 | 8 | 35253629 | ||
| Pubmed | Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. | 3.56e-06 | 46 | 78 | 4 | 23555292 | |
| Pubmed | 3.67e-06 | 183 | 78 | 6 | 36129980 | ||
| Pubmed | CEP350 PPP1R7 HSP90B1 KMT2D NCAPG LEO1 AATF HUWE1 L3MBTL3 CPSF3 CIC VAT1 | 3.70e-06 | 1049 | 78 | 12 | 27880917 | |
| Pubmed | UPF2 SAFB2 MPHOSPH10 CDK11B NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 NCBP3 | 4.42e-06 | 713 | 78 | 10 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HSP90B1 MAP1B SAFB2 MCM2 NOP2 CPSF3 SNRNP200 XAB2 VAT1 NCBP3 | 4.47e-06 | 714 | 78 | 10 | 28302793 |
| Pubmed | Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. | 4.97e-06 | 2 | 78 | 2 | 8195233 | |
| Pubmed | Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. | 4.97e-06 | 2 | 78 | 2 | 34450249 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35253468 | ||
| Pubmed | Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. | 4.97e-06 | 2 | 78 | 2 | 19484742 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11964314 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 38250155 | ||
| Pubmed | Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex. | 4.97e-06 | 2 | 78 | 2 | 36405866 | |
| Pubmed | STK3/STK4 signalling in adipocytes regulates mitophagy and energy expenditure. | 4.97e-06 | 2 | 78 | 2 | 33758424 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 26457732 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 7920654 | ||
| Pubmed | Regulated expression of a cell division control-related protein kinase during development. | 4.97e-06 | 2 | 78 | 2 | 2069872 | |
| Pubmed | A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. | 4.97e-06 | 2 | 78 | 2 | 7528743 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25986053 | ||
| Pubmed | H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization. | 4.97e-06 | 2 | 78 | 2 | 27238285 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 1774066 | ||
| Pubmed | Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. | 4.97e-06 | 2 | 78 | 2 | 8816758 | |
| Pubmed | Cloning and characterization of a member of the MST subfamily of Ste20-like kinases. | 4.97e-06 | 2 | 78 | 2 | 8566796 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 32510157 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19878874 | ||
| Pubmed | CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization. | 4.97e-06 | 2 | 78 | 2 | 28101846 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 38295774 | ||
| Pubmed | Hippo pathway regulation by cell morphology and stress fibers. | 4.97e-06 | 2 | 78 | 2 | 21831922 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30722725 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 29343826 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24874741 | ||
| Pubmed | Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. | 4.97e-06 | 2 | 78 | 2 | 10882096 | |
| Pubmed | The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. | 4.97e-06 | 2 | 78 | 2 | 27049727 | |
| Pubmed | Structure and expression of the human p58clk-1 protein kinase chromosomal gene. | 4.97e-06 | 2 | 78 | 2 | 1639388 | |
| Pubmed | Protein expression pattern of CDK11(p58) during testicular development in the mouse. | 4.97e-06 | 2 | 78 | 2 | 15792358 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15060143 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSP90B1 HDAC6 MAP1B UPF2 SAFB2 SMARCC2 LMNB2 CDK11B CPSF3 SNRNP200 GTF3C3 XAB2 | 5.07e-06 | 1082 | 78 | 12 | 38697112 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 5.83e-06 | 432 | 78 | 8 | 23455922 | |
| Pubmed | 6.58e-06 | 116 | 78 | 5 | 21549307 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 6.84e-06 | 313 | 78 | 7 | 38270169 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STK4 HSP90B1 MAP1B SAFB2 RPRD2 NOP2 CPSF3 SNRNP200 CIC XAB2 NOL8 | 7.45e-06 | 934 | 78 | 11 | 33916271 |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 7.87e-06 | 56 | 78 | 4 | 9455484 | |
| Pubmed | STK3 HSP90B1 NCAPG HDAC6 MAP1B SMARCC2 MCM2 LMNB2 HUWE1 NOP2 ANAPC5 SNRNP200 GTF3C3 | 8.02e-06 | 1335 | 78 | 13 | 29229926 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSP90B1 CHD5 SAFB2 CDK11A NOL7 AATF MPHOSPH10 CDK11B NOP2 CPSF3 SNRNP200 | 8.65e-06 | 949 | 78 | 11 | 36574265 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CEP350 STK3 STK4 PPP1R7 KANK1 HDAC6 SMARCC2 NOP2 ANAPC5 SNRNP200 GTF3C3 XAB2 | 9.79e-06 | 1155 | 78 | 12 | 20360068 |
| Pubmed | 1.00e-05 | 332 | 78 | 7 | 25693804 | ||
| Pubmed | 1.06e-05 | 335 | 78 | 7 | 15741177 | ||
| Interaction | POLR1G interactions | MDN1 LEO1 CHAF1A BCORL1 SMARCC2 CDK11A AATF RPRD2 MPHOSPH10 HUWE1 NOP2 CIC GTF3C3 NOL8 NCBP3 | 4.27e-10 | 489 | 77 | 15 | int:POLR1G |
| Interaction | PYHIN1 interactions | SATB2 MDN1 MAP1B SAFB2 MCM2 AATF PLCD1 MPHOSPH10 CDK11B HUWE1 GTF3C3 XAB2 | 1.07e-08 | 358 | 77 | 12 | int:PYHIN1 |
| Interaction | FOXK2 interactions | NPHS1 SATB2 KMT2D MAP1B CDK11A SNRNP200 MNT CIC GTF3C3 BRMS1 | 1.41e-08 | 225 | 77 | 10 | int:FOXK2 |
| Interaction | SMC5 interactions | MAP1B CHAF1A BCORL1 SAFB2 SMARCC2 CDK11A NOL7 AATF RPRD2 MPHOSPH10 CDK11B NOP2 L3MBTL3 SNRNP200 CIC XAB2 NOL8 NCBP3 | 2.91e-08 | 1000 | 77 | 18 | int:SMC5 |
| Interaction | MEN1 interactions | HSP90B1 KMT2D MDN1 UPF2 UBE4B POLA1 SAFB2 SMARCC2 MCM2 AATF MPHOSPH10 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 NOL8 NCBP3 | 4.49e-08 | 1029 | 77 | 18 | int:MEN1 |
| Interaction | H2BC21 interactions | STK4 LEO1 MAP1B CHAF1A BCORL1 SAFB2 SMARCC2 MCM2 RPRD2 SMG5 HUWE1 NOP2 L3MBTL3 ANAPC5 BAHCC1 | 4.93e-08 | 696 | 77 | 15 | int:H2BC21 |
| Interaction | POLR1E interactions | MDN1 LEO1 UTP25 BCORL1 CDK11A AATF RPRD2 MPHOSPH10 CPSF3 GTF3C3 NOL8 | 8.90e-08 | 350 | 77 | 11 | int:POLR1E |
| Interaction | DDX23 interactions | LEO1 MAP1B SAFB2 CDK11A PIP4K2B AATF MPHOSPH10 NOP2 CPSF3 SNRNP200 XAB2 NOL8 | 2.62e-07 | 480 | 77 | 12 | int:DDX23 |
| Interaction | ITGB3 interactions | 2.79e-07 | 170 | 77 | 8 | int:ITGB3 | |
| Interaction | XRCC6 interactions | HSP90B1 HDAC6 MAP1B CHAF1A SAFB2 CDK11A MCM2 RPRD2 CDK11B HUWE1 NOP2 SNRNP200 TRIM37 CIC XAB2 NOL8 | 3.50e-07 | 928 | 77 | 16 | int:XRCC6 |
| Interaction | PARP1 interactions | SATB2 NCAPG MDN1 HDAC6 LEO1 POLA1 FBXO42 BCORL1 SMARCC2 CDK11A MCM2 AATF MPHOSPH10 HUWE1 NOP2 TRIM37 CIC GTF3C3 NOL8 | 3.56e-07 | 1316 | 77 | 19 | int:PARP1 |
| Interaction | H2BC12 interactions | 4.01e-07 | 322 | 77 | 10 | int:H2BC12 | |
| Interaction | DHX40 interactions | 4.51e-07 | 249 | 77 | 9 | int:DHX40 | |
| Interaction | RBBP7 interactions | NCAPG MAP1B CHAF1A CHD5 SMARCC2 CDK11A CDK11B HUWE1 CIC VAT1 BAHCC1 BRMS1 | 4.70e-07 | 507 | 77 | 12 | int:RBBP7 |
| Interaction | DDX21 interactions | HDAC6 MAP1B FBXO42 SAFB2 CDK11A MCM2 AATF PRKD1 MPHOSPH10 HUWE1 NOP2 SNRNP200 TRIM37 CIC | 4.92e-07 | 718 | 77 | 14 | int:DDX21 |
| Interaction | RNPS1 interactions | UPF2 PDGFRA CDK11A PIP4K2B AATF CDK11B CPSF3 SNRNP200 GTF3C3 XAB2 NCBP3 | 6.17e-07 | 425 | 77 | 11 | int:RNPS1 |
| Interaction | SIRT6 interactions | SMG1 UTP25 SMARCC2 MCM2 AATF RPRD2 MPHOSPH10 CDK11B HUWE1 NOP2 ANAPC5 SNRNP200 GTF3C3 | 6.79e-07 | 628 | 77 | 13 | int:SIRT6 |
| Interaction | EIF3C interactions | 7.12e-07 | 263 | 77 | 9 | int:EIF3C | |
| Interaction | SIRT7 interactions | MDN1 UTP25 MAP1B POLA1 SMARCC2 AATF LMNB2 MPHOSPH10 HUWE1 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 | 7.52e-07 | 744 | 77 | 14 | int:SIRT7 |
| Interaction | SUZ12 interactions | KMT2D NCAPG CHAF1A SAFB2 SMARCC2 MCM2 LMNB2 NOP2 L3MBTL3 SNRNP200 TRIM37 XAB2 NCBP3 | 9.01e-07 | 644 | 77 | 13 | int:SUZ12 |
| Interaction | NR2C2 interactions | HSP90B1 NCAPG MDN1 UPF2 CHAF1A SAFB2 PRKAR2B MCM2 PIP4K2B NOL7 AATF MPHOSPH10 CDK11B HUWE1 NOP2 CPSF3 SNRNP200 CIC XAB2 | 9.43e-07 | 1403 | 77 | 19 | int:NR2C2 |
| Interaction | ZNF330 interactions | LEO1 CHAF1A BCORL1 SMARCC2 CDK11A AATF NOP2 L3MBTL3 GTF3C3 NOL8 NCBP3 | 9.91e-07 | 446 | 77 | 11 | int:ZNF330 |
| Interaction | RBBP4 interactions | NCAPG HDAC6 CHAF1A CHD5 SMARCC2 CDK11A MCM2 CDK11B HUWE1 CIC BAHCC1 BRMS1 | 1.70e-06 | 573 | 77 | 12 | int:RBBP4 |
| Interaction | EIF3F interactions | 1.90e-06 | 296 | 77 | 9 | int:EIF3F | |
| Interaction | ACTC1 interactions | HSP90B1 SATB2 HDAC6 LEO1 POLA1 SMARCC2 MCM2 RPRD2 NOP2 SNRNP200 TRIM37 CIC XAB2 | 2.07e-06 | 694 | 77 | 13 | int:ACTC1 |
| Interaction | KDM1A interactions | CEP350 SATB2 KMT2D NCAPG HDAC6 LEO1 CHAF1A BCORL1 SMARCC2 MCM2 HUWE1 L3MBTL3 CIC GTF3C3 PHF13 | 2.28e-06 | 941 | 77 | 15 | int:KDM1A |
| Interaction | SUMO2 interactions | MAF1 HSP90B1 NCAPG MDN1 POLA1 CHAF1A SAFB2 HUWE1 NOP2 SNRNP200 CIC XAB2 | 2.34e-06 | 591 | 77 | 12 | int:SUMO2 |
| Interaction | POLR2E interactions | 2.63e-06 | 308 | 77 | 9 | int:POLR2E | |
| Interaction | IFI16 interactions | STK3 HSP90B1 MAP1B SAFB2 SMARCC2 AATF MPHOSPH10 CDK11B HUWE1 NOP2 GTF3C3 XAB2 NCBP3 | 2.82e-06 | 714 | 77 | 13 | int:IFI16 |
| Interaction | DUSP16 interactions | 3.40e-06 | 237 | 77 | 8 | int:DUSP16 | |
| Interaction | NR3C1 interactions | CEP350 SMG1 HSP90B1 SATB2 KMT2D MDN1 HDAC6 FBXO42 BCORL1 SMARCC2 NOL7 AATF MPHOSPH10 CIC VAT1 | 3.49e-06 | 974 | 77 | 15 | int:NR3C1 |
| Interaction | SAP30 interactions | 3.49e-06 | 167 | 77 | 7 | int:SAP30 | |
| Interaction | SMG7 interactions | 3.50e-06 | 319 | 77 | 9 | int:SMG7 | |
| Interaction | HECTD1 interactions | NCAPG MDN1 MAP1B UPF2 SAFB2 NOL7 AATF MPHOSPH10 HUWE1 NOP2 L3MBTL3 SNRNP200 GTF3C3 NOL8 NCBP3 | 3.95e-06 | 984 | 77 | 15 | int:HECTD1 |
| Interaction | BAG2 interactions | MAP1B CHD5 BCORL1 MCM2 RPRD2 HUWE1 ANAPC5 CPSF3 TRIM37 CIC EDRF1 XAB2 | 3.95e-06 | 622 | 77 | 12 | int:BAG2 |
| Interaction | UBXN6 interactions | 4.07e-06 | 325 | 77 | 9 | int:UBXN6 | |
| Interaction | SNRPB interactions | HDAC6 LEO1 SAFB2 CC2D2A RPRD2 HUWE1 L3MBTL3 SNRNP200 CIC XAB2 NCBP3 | 4.12e-06 | 517 | 77 | 11 | int:SNRPB |
| Interaction | CAD interactions | HSP90B1 HDAC6 MAP1B CHAF1A FBXO42 SMARCC2 MCM2 PIP4K2B HUWE1 CIC | 4.21e-06 | 418 | 77 | 10 | int:CAD |
| Interaction | HSP90AA1 interactions | SMG1 HSP90B1 HDAC6 MAP1B POLA1 ITGB1BP2 VPS41 CDK11A MCM2 PRKD1 CDK11B HUWE1 SNRNP200 TRIM37 CIC EDRF1 BRMS1 | 4.32e-06 | 1263 | 77 | 17 | int:HSP90AA1 |
| Interaction | RNF2 interactions | KMT2D BCORL1 SMARCC2 CDK11A NOL7 LMNB2 MPHOSPH10 CDK11B HUWE1 NOP2 SNRNP200 CIC XAB2 NCBP3 | 4.45e-06 | 866 | 77 | 14 | int:RNF2 |
| Interaction | USP9X interactions | HDAC6 MAP1B UBE4B CHAF1A FBXO42 MCM2 PRKD1 HUWE1 SNRNP200 GTF3C3 | 4.57e-06 | 422 | 77 | 10 | int:USP9X |
| Interaction | MTA2 interactions | SATB2 NCAPG CHAF1A CHD5 SMARCC2 CDK11A OTUD3 CDK11B RFX3 CIC | 5.97e-06 | 435 | 77 | 10 | int:MTA2 |
| Interaction | HSP90B1 interactions | SMG1 CACNA1F HSP90B1 HDAC6 MAP1B UPF2 SMARCC2 MCM2 AK9 MPHOSPH10 HUWE1 TRIM37 | 6.19e-06 | 650 | 77 | 12 | int:HSP90B1 |
| Interaction | LHX2 interactions | 6.39e-06 | 183 | 77 | 7 | int:LHX2 | |
| Interaction | H2BC4 interactions | 6.54e-06 | 259 | 77 | 8 | int:H2BC4 | |
| Interaction | MED4 interactions | CEP350 NCAPG MAP1B CDK11A PIP4K2B RPRD2 HUWE1 NOP2 CPSF3 EDRF1 | 8.04e-06 | 450 | 77 | 10 | int:MED4 |
| Interaction | FOXL1 interactions | 1.00e-05 | 196 | 77 | 7 | int:FOXL1 | |
| Interaction | SMARCAD1 interactions | 1.03e-05 | 197 | 77 | 7 | int:SMARCAD1 | |
| Interaction | SSRP1 interactions | SATB2 HDAC6 LEO1 POLA1 CHAF1A SAFB2 MCM2 RPRD2 HUWE1 NOP2 SNRNP200 CIC | 1.05e-05 | 685 | 77 | 12 | int:SSRP1 |
| Interaction | RPS7 interactions | 1.09e-05 | 466 | 77 | 10 | int:RPS7 | |
| Interaction | CHD4 interactions | NCAPG MDN1 LEO1 CHAF1A CHD5 SMARCC2 CDK11A MCM2 CDK11B NOP2 SNRNP200 CIC XAB2 NCBP3 | 1.10e-05 | 938 | 77 | 14 | int:CHD4 |
| Interaction | DDA1 interactions | 1.11e-05 | 368 | 77 | 9 | int:DDA1 | |
| Interaction | RUVBL1 interactions | SMG1 NCAPG HDAC6 MAP1B CHAF1A SMARCC2 MCM2 HUWE1 SNRNP200 CIC VAT1 | 1.13e-05 | 575 | 77 | 11 | int:RUVBL1 |
| Interaction | ZNF554 interactions | 1.15e-05 | 12 | 77 | 3 | int:ZNF554 | |
| Interaction | RAD50 interactions | 1.18e-05 | 371 | 77 | 9 | int:RAD50 | |
| Interaction | TOP1 interactions | HDAC6 LEO1 PDGFRA POLA1 SAFB2 SMARCC2 MCM2 RPRD2 NOP2 SNRNP200 GTF3C3 XAB2 | 1.23e-05 | 696 | 77 | 12 | int:TOP1 |
| Interaction | CENPA interactions | 1.34e-05 | 377 | 77 | 9 | int:CENPA | |
| Interaction | MRE11 interactions | 1.38e-05 | 287 | 77 | 8 | int:MRE11 | |
| Interaction | SIN3A interactions | 1.43e-05 | 380 | 77 | 9 | int:SIN3A | |
| Interaction | SOX7 interactions | 1.55e-05 | 82 | 77 | 5 | int:SOX7 | |
| Interaction | H3C3 interactions | 1.83e-05 | 495 | 77 | 10 | int:H3C3 | |
| Interaction | RUVBL2 interactions | SMG1 NCAPG HDAC6 LEO1 MAP1B CHAF1A FBXO42 HUWE1 SNRNP200 CIC VAT1 | 2.13e-05 | 616 | 77 | 11 | int:RUVBL2 |
| Interaction | H2AC4 interactions | 2.21e-05 | 506 | 77 | 10 | int:H2AC4 | |
| Interaction | SMC3 interactions | 2.50e-05 | 408 | 77 | 9 | int:SMC3 | |
| Interaction | EED interactions | STK4 PPP1R7 HSP90B1 MAP1B UBE4B VPS41 SAFB2 SMARCC2 MCM2 LMNB2 HUWE1 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 VAT1 | 2.52e-05 | 1445 | 77 | 17 | int:EED |
| Interaction | H3-3A interactions | KMT2D PDGFRA POLA1 CHAF1A CHD5 BCORL1 SMARCC2 MCM2 CDK11B CIC GTF3C3 NCBP3 | 2.55e-05 | 749 | 77 | 12 | int:H3-3A |
| Interaction | PRNP interactions | CEP350 HSP90B1 KANK1 MDN1 HDAC6 MAP1B POLA1 CHAF1A BCORL1 PRKAR2B RPRD2 PRKD1 LMNB2 CIC NOL8 | 2.74e-05 | 1158 | 77 | 15 | int:PRNP |
| Interaction | FBL interactions | UTP25 BCORL1 MCM2 NOL7 AATF MPHOSPH10 NOP2 TRIM37 CIC GTF3C3 NOL8 | 2.99e-05 | 639 | 77 | 11 | int:FBL |
| Interaction | CCT8L2 interactions | 3.05e-05 | 157 | 77 | 6 | int:CCT8L2 | |
| Interaction | RPL4 interactions | STK3 HDAC6 FBXO42 AATF PRKD1 MPHOSPH10 HUWE1 NOP2 SNRNP200 TRIM37 CIC NOL8 | 3.09e-05 | 764 | 77 | 12 | int:RPL4 |
| Interaction | CHAF1A interactions | 3.15e-05 | 322 | 77 | 8 | int:CHAF1A | |
| Interaction | RBM25 interactions | 3.22e-05 | 323 | 77 | 8 | int:RBM25 | |
| Interaction | RAE1 interactions | 3.31e-05 | 236 | 77 | 7 | int:RAE1 | |
| Interaction | MKI67 interactions | SMG1 HSP90B1 KMT2D MAP1B MCM2 LMNB2 MPHOSPH10 RFX3 SNRNP200 TRIM37 NCBP3 | 3.39e-05 | 648 | 77 | 11 | int:MKI67 |
| Interaction | OBSL1 interactions | DNAAF8 HSP90B1 MDN1 SAFB2 SMARCC2 MCM2 AATF LMNB2 HUWE1 NOP2 SNRNP200 XAB2 NCBP3 | 3.42e-05 | 902 | 77 | 13 | int:OBSL1 |
| Interaction | HULC interactions | 3.52e-05 | 161 | 77 | 6 | int:HULC | |
| Interaction | POLR2A interactions | 3.61e-05 | 536 | 77 | 10 | int:POLR2A | |
| Interaction | CFAP184 interactions | 3.64e-05 | 162 | 77 | 6 | int:CFAP184 | |
| Interaction | VCPIP1 interactions | 3.64e-05 | 162 | 77 | 6 | int:VCPIP1 | |
| Interaction | CPNE4 interactions | 3.66e-05 | 49 | 77 | 4 | int:CPNE4 | |
| Interaction | EIF3CL interactions | 3.67e-05 | 98 | 77 | 5 | int:EIF3CL | |
| Interaction | CCDC8 interactions | CEP350 HSP90B1 MDN1 MAP1B PDGFRA SMARCC2 MCM2 LMNB2 HUWE1 NOP2 SNRNP200 | 3.79e-05 | 656 | 77 | 11 | int:CCDC8 |
| Interaction | RPL27 interactions | 3.84e-05 | 431 | 77 | 9 | int:RPL27 | |
| Interaction | DDX41 interactions | 4.17e-05 | 166 | 77 | 6 | int:DDX41 | |
| Interaction | ZNF189 interactions | 4.30e-05 | 51 | 77 | 4 | int:ZNF189 | |
| Interaction | EIF3B interactions | 4.34e-05 | 337 | 77 | 8 | int:EIF3B | |
| Interaction | KPNA3 interactions | 4.54e-05 | 248 | 77 | 7 | int:KPNA3 | |
| Interaction | PTEN interactions | DNAAF8 HSP90B1 MDN1 HDAC6 PDGFRA PRKAR2B MCM2 OTUD3 ANAPC5 SNRNP200 TRIM37 GTF3C3 VAT1 | 4.63e-05 | 929 | 77 | 13 | int:PTEN |
| Interaction | MYH2 interactions | 5.00e-05 | 53 | 77 | 4 | int:MYH2 | |
| Interaction | CTPS1 interactions | 5.02e-05 | 252 | 77 | 7 | int:CTPS1 | |
| Interaction | DOT1L interactions | HSP90B1 MDN1 SAFB2 SMARCC2 AATF MPHOSPH10 NOP2 CPSF3 SNRNP200 GTF3C3 XAB2 NOL8 | 5.26e-05 | 807 | 77 | 12 | int:DOT1L |
| Interaction | PPP6R3 interactions | 5.82e-05 | 258 | 77 | 7 | int:PPP6R3 | |
| Interaction | CSNK2A1 interactions | MAF1 HSP90B1 LEO1 SMARCC2 CDK11A MCM2 PIP4K2B RPRD2 MPHOSPH10 CDK11B CIC GTF3C3 BRMS1 | 6.21e-05 | 956 | 77 | 13 | int:CSNK2A1 |
| Interaction | SLX4 interactions | CEP350 HSP90B1 MDN1 CDK11A AATF RPRD2 SNRNP200 GTF3C3 XAB2 NOL8 | 6.23e-05 | 572 | 77 | 10 | int:SLX4 |
| Interaction | EIF4A1 interactions | 6.26e-05 | 355 | 77 | 8 | int:EIF4A1 | |
| Interaction | NPM3 interactions | 6.42e-05 | 262 | 77 | 7 | int:NPM3 | |
| Interaction | PPP1CA interactions | PPP1R7 KANK1 HDAC6 LEO1 CHAF1A RPRD2 PRKD1 MPHOSPH10 HUWE1 PARD3 CIC | 6.47e-05 | 696 | 77 | 11 | int:PPP1CA |
| Interaction | YWHAG interactions | CEP350 STK3 STK4 KANK1 MDN1 CHAF1A MCM2 PRKD1 CDK11B HUWE1 PARD3 CPSF3 SNRNP200 CIC EDRF1 | 6.47e-05 | 1248 | 77 | 15 | int:YWHAG |
| Interaction | HSP90AB1 interactions | HSP90B1 FCHSD2 HDAC6 MAP1B POLA1 ITGB1BP2 SMARCC2 CDK11A MCM2 HUWE1 TRIM37 CIC EDRF1 | 6.48e-05 | 960 | 77 | 13 | int:HSP90AB1 |
| Interaction | PAXIP1 interactions | 6.77e-05 | 359 | 77 | 8 | int:PAXIP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.63e-04 | 681 | 78 | 7 | chr1p36 | |
| Cytoband | 1p36.31 | 2.56e-04 | 14 | 78 | 2 | 1p36.31 | |
| Cytoband | 8q22.2 | 7.04e-04 | 23 | 78 | 2 | 8q22.2 | |
| Cytoband | 19p13.3 | 7.32e-04 | 237 | 78 | 4 | 19p13.3 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.04e-04 | 181 | 47 | 5 | 694 | |
| GeneFamily | Basic helix-loop-helix proteins|MAX dimerization proteins | 1.38e-04 | 7 | 47 | 2 | 637 | |
| GeneFamily | Adenylate kinases | 2.35e-04 | 9 | 47 | 2 | 356 | |
| GeneFamily | PHD finger proteins | 1.65e-03 | 90 | 47 | 3 | 88 | |
| GeneFamily | Cyclin dependent kinases | 2.07e-03 | 26 | 47 | 2 | 496 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | STK3 SMG1 HSP90B1 NCAPG UTP25 POLA1 CHAF1A MCM2 AATF LMNB2 TICAM2 NOP2 ANAPC5 CPSF3 EDRF1 GTF3C3 NOL8 | 5.29e-07 | 1407 | 77 | 17 | M14427 |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP | 2.08e-06 | 200 | 77 | 7 | M6832 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 9.09e-06 | 466 | 77 | 9 | M13522 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_UP | 2.19e-05 | 114 | 77 | 5 | M2895 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_UP | 2.39e-05 | 116 | 77 | 5 | MM1090 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP | 2.77e-05 | 200 | 77 | 6 | M4442 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 7.64e-05 | 612 | 77 | 9 | M4772 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.24e-04 | 378 | 77 | 7 | M41174 | |
| Coexpression | PATIL_LIVER_CANCER | 1.35e-04 | 660 | 77 | 9 | M1195 | |
| Coexpression | ESC_J1_UP_LATE.V1_DN | 1.39e-04 | 168 | 77 | 5 | M2765 | |
| Coexpression | LI_DCP2_BOUND_MRNA | 1.39e-04 | 89 | 77 | 4 | M2188 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D2 | 1.91e-04 | 38 | 77 | 3 | M12861 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.99e-04 | 856 | 77 | 10 | M4500 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.56e-04 | 300 | 77 | 6 | M8702 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 2.84e-04 | 196 | 77 | 5 | M5358 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 2.84e-04 | 196 | 77 | 5 | M4928 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN | 2.84e-04 | 196 | 77 | 5 | M6174 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 2.88e-04 | 434 | 77 | 7 | M15150 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_UP | 2.90e-04 | 197 | 77 | 5 | M3345 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP | 2.97e-04 | 198 | 77 | 5 | M3449 | |
| Coexpression | GSE39022_LN_VS_SPLEEN_DC_DN | 2.97e-04 | 198 | 77 | 5 | M9018 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | 3.04e-04 | 199 | 77 | 5 | M7711 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP | 3.04e-04 | 199 | 77 | 5 | M7650 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKCELL_UP | 3.04e-04 | 199 | 77 | 5 | M4836 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 3.04e-04 | 199 | 77 | 5 | M7099 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 3.04e-04 | 199 | 77 | 5 | M5251 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 3.04e-04 | 199 | 77 | 5 | M4444 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP | 3.11e-04 | 200 | 77 | 5 | M9470 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN | 3.11e-04 | 200 | 77 | 5 | M7796 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 3.11e-04 | 200 | 77 | 5 | M6254 | |
| Coexpression | GSE15330_HSC_VS_PRO_BCELL_UP | 3.11e-04 | 200 | 77 | 5 | M7056 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN | 3.11e-04 | 200 | 77 | 5 | M5292 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_UP | 3.11e-04 | 200 | 77 | 5 | M5160 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 3.11e-04 | 200 | 77 | 5 | M9205 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 3.11e-04 | 200 | 77 | 5 | M5777 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.11e-04 | 200 | 77 | 5 | M6993 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 3.48e-04 | 113 | 77 | 4 | M2291 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 3.49e-04 | 448 | 77 | 7 | MM1044 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 3.87e-04 | 761 | 77 | 9 | M11961 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 4.10e-04 | 118 | 77 | 4 | M15305 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN | 4.33e-04 | 50 | 77 | 3 | M5077 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | STK4 SMG1 CACNA1F MAP1B UPF2 RPRD2 CDK11B SNRNP200 MNT TRIM37 ZNF654 EDRF1 | 1.27e-06 | 595 | 76 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | STK4 PPP1R7 KANK1 NCAPG LEO1 MAP1B POLA1 BCORL1 MPHOSPH10 RFX3 NOL8 | 2.90e-06 | 532 | 76 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.92e-06 | 333 | 76 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | STK4 FCHSD2 UTP25 UPF2 POLA1 BCORL1 MPHOSPH10 CDK11B PARD3 NOL8 | 6.51e-06 | 469 | 76 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.25e-05 | 328 | 76 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | SATB2 NCAPG MDN1 POLA1 MCM2 AATF MPHOSPH10 NOP2 TRIM37 GTF3C3 NOL8 PHF13 | 2.40e-05 | 795 | 76 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | SATB2 NCAPG MDN1 UBE4B POLA1 AATF MPHOSPH10 NOP2 TRIM37 GTF3C3 NOL8 PHF13 | 2.88e-05 | 810 | 76 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.03e-05 | 463 | 76 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SMG1 SATB2 NCAPG MDN1 POLA1 PRKAR2B AATF HUWE1 TRIM37 EDRF1 NOL8 | 1.54e-04 | 820 | 76 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.84e-04 | 232 | 76 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NPHS1 HSP90B1 NCAPG MDN1 HDAC6 LEO1 MAP1B CHAF1A MCM2 MPHOSPH10 CDK11B RFX3 NOP2 NOL8 | 3.22e-04 | 1371 | 76 | 14 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.85e-07 | 172 | 78 | 6 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.41e-06 | 200 | 78 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-06 | 118 | 78 | 5 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-06 | 118 | 78 | 5 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.16e-05 | 168 | 78 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 173 | 78 | 5 | 28c98a9a54aa2cfa67464db4f628c9357ad185b9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-05 | 178 | 78 | 5 | 91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-05 | 178 | 78 | 5 | be4976bbfd9ebbc568155ede99a07670c43aa372 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-05 | 185 | 78 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 191 | 78 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.26e-05 | 193 | 78 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 194 | 78 | 5 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.32e-05 | 194 | 78 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 194 | 78 | 5 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.32e-05 | 194 | 78 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 194 | 78 | 5 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 195 | 78 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.49e-05 | 197 | 78 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-05 | 198 | 78 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-05 | 199 | 78 | 5 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 2.68e-05 | 200 | 78 | 5 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.68e-05 | 200 | 78 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.68e-05 | 200 | 78 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.31e-05 | 135 | 78 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 2.06e-04 | 166 | 78 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 168 | 78 | 4 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 171 | 78 | 4 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 172 | 78 | 4 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 173 | 78 | 4 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 173 | 78 | 4 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 173 | 78 | 4 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 173 | 78 | 4 | 5086edc29c5a6137ca09877929a1317f9739c801 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 176 | 78 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.58e-04 | 176 | 78 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 2.58e-04 | 176 | 78 | 4 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-04 | 177 | 78 | 4 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 178 | 78 | 4 | 79823d13652177de852c2acce9159049241f1d86 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 179 | 78 | 4 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-04 | 179 | 78 | 4 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 180 | 78 | 4 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.81e-04 | 180 | 78 | 4 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.81e-04 | 180 | 78 | 4 | 3c605d6adb4199963532f3639f2c768f7e575152 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-04 | 180 | 78 | 4 | 3d52ca0568f9c0d6359b302ff5ff41b075f78597 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 183 | 78 | 4 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-04 | 184 | 78 | 4 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-04 | 184 | 78 | 4 | 7f8488dbb1ee41372cdbcd34a2e14b377218bf0f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-04 | 184 | 78 | 4 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.05e-04 | 184 | 78 | 4 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 184 | 78 | 4 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | Multiple_Sclerosis-Other-Platelet|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.11e-04 | 185 | 78 | 4 | 2e480dde7ecb2f88ff005f86ef732a1cf0209d45 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-04 | 185 | 78 | 4 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.11e-04 | 185 | 78 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-04 | 185 | 78 | 4 | 709236097cbfc254796fcc69b5f5178b73dad9bd | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.11e-04 | 185 | 78 | 4 | af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-04 | 188 | 78 | 4 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 188 | 78 | 4 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | severe_influenza-Platelet|World / disease group, cell group and cell class (v2) | 3.31e-04 | 188 | 78 | 4 | b54632baa682aaf51100d44e7f114a54d5edd695 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-04 | 189 | 78 | 4 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-04 | 189 | 78 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.38e-04 | 189 | 78 | 4 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-04 | 189 | 78 | 4 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.44e-04 | 190 | 78 | 4 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.44e-04 | 190 | 78 | 4 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 191 | 78 | 4 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 191 | 78 | 4 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 191 | 78 | 4 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.58e-04 | 192 | 78 | 4 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.58e-04 | 192 | 78 | 4 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.65e-04 | 193 | 78 | 4 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.65e-04 | 193 | 78 | 4 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-04 | 193 | 78 | 4 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.65e-04 | 193 | 78 | 4 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-04 | 193 | 78 | 4 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.65e-04 | 193 | 78 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.65e-04 | 193 | 78 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.73e-04 | 194 | 78 | 4 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-04 | 194 | 78 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.73e-04 | 194 | 78 | 4 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 194 | 78 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-04 | 195 | 78 | 4 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.80e-04 | 195 | 78 | 4 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.80e-04 | 195 | 78 | 4 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-04 | 195 | 78 | 4 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.80e-04 | 195 | 78 | 4 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.80e-04 | 195 | 78 | 4 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-04 | 195 | 78 | 4 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 195 | 78 | 4 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-04 | 195 | 78 | 4 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.80e-04 | 195 | 78 | 4 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 195 | 78 | 4 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.80e-04 | 195 | 78 | 4 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-04 | 196 | 78 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.87e-04 | 196 | 78 | 4 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 196 | 78 | 4 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.87e-04 | 196 | 78 | 4 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.87e-04 | 196 | 78 | 4 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 196 | 78 | 4 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.95e-04 | 197 | 78 | 4 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| Computational | Neighborhood of EIF3S2 | 1.68e-04 | 246 | 52 | 7 | MORF_EIF3S2 | |
| Computational | Neighborhood of DNMT1 | 2.52e-04 | 118 | 52 | 5 | MORF_DNMT1 | |
| Computational | Neighborhood of PRKDC | 3.00e-04 | 191 | 52 | 6 | MORF_PRKDC | |
| Computational | Neighborhood of RPA2 | 3.18e-04 | 193 | 52 | 6 | MORF_RPA2 | |
| Computational | Neighborhood of DAP3 | 3.36e-04 | 195 | 52 | 6 | MORF_DAP3 | |
| Computational | Neighborhood of AATF | 4.86e-04 | 209 | 52 | 6 | MORF_AATF | |
| Computational | Neighborhood of XRCC5 | 8.99e-04 | 235 | 52 | 6 | MORF_XRCC5 | |
| Computational | Neighborhood of DDB1 | 1.14e-03 | 246 | 52 | 6 | MORF_DDB1 | |
| Computational | Neighborhood of PPP1CC | 1.20e-03 | 166 | 52 | 5 | MORF_PPP1CC | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 4.40e-06 | 195 | 77 | 7 | 630_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.55e-06 | 196 | 77 | 7 | 5830_DN | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 2.35e-05 | 169 | 77 | 6 | 5225_UP | |
| Drug | resveratrol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.34e-05 | 180 | 77 | 6 | 958_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 3.67e-05 | 183 | 77 | 6 | 6985_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.90e-05 | 185 | 77 | 6 | 831_UP | |
| Drug | C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.94e-05 | 193 | 77 | 6 | 865_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 5.08e-05 | 194 | 77 | 6 | 2632_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.08e-05 | 194 | 77 | 6 | 4952_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 2649_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 3416_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 6615_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 4125_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 3327_DN | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; PC3; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 4022_UP | |
| Drug | Tribenoside [10310-32-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 5429_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 2312_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 5815_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 3406_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 3537_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 5533_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 4090_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 5835_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; HL60; HG-U133A | 5.69e-05 | 198 | 77 | 6 | 1376_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 7334_DN | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 3472_DN | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 5405_DN | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 6525_DN | |
| Drug | Clebopride maleate [84370-95-6]; Down 200; 8.2uM; HL60; HT_HG-U133A | 5.85e-05 | 199 | 77 | 6 | 1292_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HG-U133A | 6.02e-05 | 200 | 77 | 6 | 1896_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 6.02e-05 | 200 | 77 | 6 | 2061_DN | |
| Drug | arsanilic acid | 6.27e-05 | 23 | 77 | 3 | CID000007389 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.80e-04 | 170 | 77 | 5 | 1631_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.12e-04 | 174 | 77 | 5 | 972_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 3.20e-04 | 175 | 77 | 5 | 1653_UP | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 3.55e-04 | 179 | 77 | 5 | 4452_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.64e-04 | 180 | 77 | 5 | 3290_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 4.03e-04 | 184 | 77 | 5 | 4449_UP | |
| Drug | 2c5o | 4.03e-04 | 284 | 77 | 6 | CID000447956 | |
| Drug | PtdIns(4)P | 4.30e-04 | 104 | 77 | 4 | CID000643965 | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 4.34e-04 | 187 | 77 | 5 | 3677_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.44e-04 | 188 | 77 | 5 | 4545_DN | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.55e-04 | 189 | 77 | 5 | 836_UP | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.66e-04 | 190 | 77 | 5 | 4306_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.78e-04 | 191 | 77 | 5 | 2055_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.78e-04 | 191 | 77 | 5 | 1057_DN | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A | 4.78e-04 | 191 | 77 | 5 | 2041_UP | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; PC3; HT_HG-U133A | 4.78e-04 | 191 | 77 | 5 | 6658_DN | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 4.78e-04 | 191 | 77 | 5 | 7376_DN | |
| Drug | methylselenic acid | 4.89e-04 | 412 | 77 | 7 | ctd:C008493 | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.89e-04 | 192 | 77 | 5 | 5401_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.89e-04 | 192 | 77 | 5 | 6990_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.89e-04 | 192 | 77 | 5 | 3753_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.89e-04 | 192 | 77 | 5 | 5058_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.89e-04 | 192 | 77 | 5 | 1076_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 4.89e-04 | 192 | 77 | 5 | 6986_DN | |
| Drug | AC1LAJ7C | 4.99e-04 | 10 | 77 | 2 | CID000469401 | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | 5.01e-04 | 193 | 77 | 5 | 1988_UP | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | 5.01e-04 | 193 | 77 | 5 | 4118_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 5.01e-04 | 193 | 77 | 5 | 1657_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 5.01e-04 | 193 | 77 | 5 | 462_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.01e-04 | 193 | 77 | 5 | 3841_DN | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.13e-04 | 194 | 77 | 5 | 6070_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 5.13e-04 | 194 | 77 | 5 | 2087_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.13e-04 | 194 | 77 | 5 | 2779_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A | 5.13e-04 | 194 | 77 | 5 | 3035_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 5.13e-04 | 194 | 77 | 5 | 1179_DN | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 6913_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 2621_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 5307_DN | |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | 5.25e-04 | 195 | 77 | 5 | 1108_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 7225_DN | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 7403_UP | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 4358_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 2050_DN | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 5840_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 1652_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 3530_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 1160_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 1527_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 2359_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; HL60; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 2552_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 5.25e-04 | 195 | 77 | 5 | 3358_DN | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 5301_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 4361_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 5.37e-04 | 196 | 77 | 5 | 2_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 5293_DN | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 7265_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 4982_DN | |
| Drug | 4-dideoxy-1,4-imino-D-xylitol | 5.37e-04 | 196 | 77 | 5 | CID000001335 | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A | 5.37e-04 | 196 | 77 | 5 | 1982_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 4834_DN | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 3029_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 7382_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 3277_UP | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 4685_UP | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 3390_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 5863_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.37e-04 | 196 | 77 | 5 | 1001_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 5.37e-04 | 196 | 77 | 5 | 2108_DN | |
| Disease | cancer (implicated_via_orthology) | 6.32e-05 | 268 | 75 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | nicotine dependence symptom count | 8.87e-05 | 285 | 75 | 6 | EFO_0009262 | |
| Disease | Cleft palate, isolated | 1.69e-04 | 42 | 75 | 3 | C1837218 | |
| Disease | Colorectal Carcinoma | 4.09e-04 | 702 | 75 | 8 | C0009402 | |
| Disease | Craniofacial Abnormalities | 6.83e-04 | 156 | 75 | 4 | C0376634 | |
| Disease | Cleft Palate | 1.17e-03 | 81 | 75 | 3 | C0008925 | |
| Disease | obesity (implicated_via_orthology) | 2.22e-03 | 215 | 75 | 4 | DOID:9970 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEEMVTEAEANREDD | 1031 | Q5RHP9 | |
| DELEEDELGQQSMED | 1256 | Q9P281 | |
| NEDEMSEEEDGGLEA | 21 | Q8TDI0 | |
| EEGSEDDESLREMVE | 656 | Q9UKF6 | |
| SSDQEGDDPMEEDDF | 1656 | Q5H9F3 | |
| EVSEEEMSEDEEREN | 351 | P21127 | |
| TIDEEAAGDETMEAR | 561 | Q8TF21 | |
| DMDGFQADTEEEEEE | 896 | Q13111 | |
| QADTEEEEEEEGDCM | 901 | Q13111 | |
| ADTKEDGEERDDEME | 181 | Q96JM7 | |
| RATEDGEEDEEMIES | 156 | P49736 | |
| EDADMELTSRDEGER | 171 | Q9UJX4 | |
| MSEEESSDVEIRNEE | 61 | P16234 | |
| EEEEGARREGADMEE | 796 | O60840 | |
| DQEETVLEGTMDQDE | 16 | Q6P3S6 | |
| ERLGEDEEDQSLDDM | 776 | O60500 | |
| DEFEDEEMLDEEGRT | 396 | Q8WVC0 | |
| ESDVVMEEGSDDNDS | 336 | Q15139 | |
| AEGEEEMDTGADDQD | 4951 | Q9NU22 | |
| ESDDTDTENERRDMA | 651 | Q9Y561 | |
| DNGVSGREDDDDVEM | 761 | Q9Y561 | |
| STDDSEQEVDIEGME | 151 | Q14582 | |
| ESVASGDDRAEEDMD | 991 | P46821 | |
| DMELGEEEVEEESRS | 221 | Q9H063 | |
| GVVLEMDEEESDDSD | 316 | Q9UKP3 | |
| SEEEEEMPDSDENGS | 536 | Q3B7T1 | |
| SVMRENENGEEEEEE | 581 | Q03252 | |
| EEEEDQDMDADDRVV | 356 | Q53F19 | |
| EEEEDEDTRGMAEGH | 1036 | Q14678 | |
| TASEGEDNIDEDMEE | 331 | Q99583 | |
| EDNIDEDMEEDRAGL | 336 | Q99583 | |
| EDLEEEEVSDMGNDD | 131 | O00566 | |
| DDDLTDSEMDVVRFD | 366 | P00451 | |
| MDSRFLETDSEEEQE | 881 | Q76FK4 | |
| RSGEDESQEDVLMDE | 2371 | Q7Z6Z7 | |
| ESTEEEQESGAMEFE | 236 | P09884 | |
| EAMVDEGQLASEEEE | 16 | Q9UMY1 | |
| GMDSEDDLRDEVEDA | 221 | Q5T2D3 | |
| DEDEAAEMEDEAVRS | 461 | P51178 | |
| TEDTEQDEDEEMDVG | 771 | P14625 | |
| ITEEFIENDEDADMG | 11 | Q9P2K1 | |
| DESMTEDEIEEQSFR | 1611 | Q5VT06 | |
| DSEEEEEEEMAALGD | 401 | Q8IYS4 | |
| SEEEMSEDEERENEN | 341 | Q9UQ88 | |
| MQSDSEDGEEEEAAP | 81 | P31323 | |
| TEREEGEEFEDNMDV | 441 | O94868 | |
| ERDNMEEDNVEESEE | 446 | Q9UBN7 | |
| MEVDRRVESEESGDE | 16 | Q15435 | |
| RDVEDMELSDVEDDG | 366 | Q5VT52 | |
| DDEGMETLEEDTEES | 941 | Q8TEW0 | |
| DSMTEGENLEEDEEE | 1021 | Q9HAU5 | |
| EMSGEEDEEQETDAI | 1246 | Q5TCS8 | |
| EDSIVDDAEMNDEDG | 96 | Q68CQ4 | |
| METASELGREEEDDV | 311 | Q9HCS7 | |
| TEENDIDEETMSGEN | 546 | O94972 | |
| SRSDLEDMEEEEGTR | 521 | Q9UPR3 | |
| DEGSEVESEMDEELD | 671 | P48380 | |
| MEVEERAEDEECEND | 296 | P78356 | |
| QITESEDNEEDDMVD | 1691 | Q96Q15 | |
| TESEENDSEEGSEEM | 696 | Q9UPW6 | |
| GAQSVEEMFEEEAEE | 61 | Q86XR7 | |
| EEEDSEEDGMVNHGD | 116 | P46087 | |
| DEQEDESMETTGKDE | 381 | Q8TAQ2 | |
| FASMLGENEDDEEEE | 86 | Q9Y5Q9 | |
| MAAEEEEVDSADTGE | 1 | Q8WTS1 | |
| AEMNGEEEESEEERS | 21 | Q9HCU9 | |
| EESGMEEGDDAEDSQ | 176 | Q9NY61 | |
| SDEERMVICEEEGDD | 436 | Q96RK0 | |
| QSDMEDDEEEEDGGL | 81 | Q9BPX3 | |
| DEDSTGNDEDIMVDS | 211 | Q86YI8 | |
| DLGTMVINSEDEEEE | 361 | Q13188 | |
| MSDEQSKEEESEDGR | 11 | A0A1B0GVG6 | |
| DVDSGIENMEVDEND | 121 | O95155 | |
| MAEEESDQEAERLGE | 1 | Q8IZM8 | |
| EDDSRDGQEDMEASL | 106 | Q14151 | |
| MAEAEEQETGSLEES | 1 | P49754 | |
| REEASDDDMEGDEAV | 221 | O75643 | |
| MSDEREVAEAATGED | 1 | Q99536 | |
| DEENSEEDEMDSGTM | 316 | Q13043 | |
| NQTEDVRMESDEDSD | 4686 | O14686 | |
| QEDEEEEDDVRGRMF | 496 | Q96M32 |